Regulation effect of Aspirin Eugenol Ester on blood lipids in Wistar rats with hyperlipidemia.

Abstract

BACKGROUND:

Aspirin eugenol ester (AEE) is a promising drug candidate for treatment of inflammation, pain and fever and prevention of cardiovascular diseases with less side effects. The experiment will be conducted to investigate the efficacy of AEE on curing hyperlipidemia in Wistar rats. The rats were fed with high fat diet (HFD) for 8 weeks to induce hyperlipidemia.

RESULTS:

Compared with the model group, the results showed that AEE at 54 mg/kg dosage could significantly decrease the hyperlipidemia indexes including triglyceride (TG), low density lipoprotein (LDL) and total cholesterol (TCH) (p < 0.01), increase high density lipoprotein (HDL) (p < 0.05) for five weeks drug administration. Meanwhile, simvastatin had same effect on hyperlipidemia indexes such as TG, LDL, TC, but no significant increase in HDL.

CONCLUSION:

AEE was effective against hyperlipidemia and had better anti-hyperlipidemic effect than its component, acetylsalicylic acid (Aspirin, ASA), eugenol and integration of ASA and eugenol. Under the experimental circumstance, the optimal dose of AEE to cure hyperlipidemia is 54 mg/kg for five weeks in Wistar rats.

• Authors: Isam Karam, Ning Ma, Xi-Wang Liu, Shi-Hong Li, Xiao-Jun Kong, Jian-Yong Li, Ya-Jun Yang
• Journal: BMC veterinary research (BMC Vet Res) Vol. 11 Pg. 217 (Aug 20 2015) ISSN: 1746-6148 [Electronic] England
• PMID: 26289078 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Dietary Fats
• Hypolipidemic Agents
• aspirin eugenol ester
• Eugenol
• Simvastatin
• Aspirin

Topics

• Animals
• Aspirin (analogs & derivatives, pharmacology)
• Dietary Fats (adverse effects)
• Eugenol (analogs & derivatives, pharmacology)
• Hyperlipidemias (chemically induced, drug therapy)
• Hypolipidemic Agents (therapeutic use)
• Male
• Random Allocation
• Rats
• Simvastatin (therapeutic use)